Seres and Nestle launch a poop pill for your gut biome
Seres Therapeutics Inc. plans to start selling its first FDA-approved product, a drug called Vowst made of bacterial spores derived from donated feces, this summer at $17,500 a course.
Seres Therapeutics Inc. plans to start selling its first FDA-approved product, a drug called Vowst made of bacterial spores derived from donated feces, this summer at $17,500 a course.
StoreDot is the latest Israeli startup to wow the world with a groundbreaking new charger that takes a cell phone battery from 27 percent to 100 percent in 30 seconds flat.